Company Filing History:
Years Active: 2008-2013
Title: **Daad Sayegh: Pioneering Cancer Treatment Innovations**
Introduction
Daad Sayegh, an innovative inventor based in Mississauga, Canada, has made significant contributions to the field of cancer research. With a remarkable portfolio of six patents, he is recognized for his advancements in cancer diagnosis and treatment, specifically focusing on the mediation of cytotoxicity of tumor cells.
Latest Patents
Among his latest patents is the invention titled "Cytotoxicity mediation of cells evidencing surface expression of CD44." This groundbreaking work pertains to the diagnosis and treatment of cancerous diseases. It emphasizes the mediation of cytotoxicity of both primary and metastatic human tumor cells. The invention highlights the use of isolated monoclonal antibodies, or cancerous disease modifying antibodies (CDMAB), in conjunction with one or more chemotherapeutic agents. This innovative approach is aimed at initiating a cytotoxic response in human tumors originating from hepatocytes. Additionally, the patent includes binding assays utilizing the CDMAB, paving the way for enhanced cancer treatment methods.
Career Highlights
Throughout his career, Daad Sayegh has been associated with notable companies such as Arius Research, Inc. and Hoffmann-La Roche Inc. His expertise and dedication have led to significant advancements in cancer treatment methodologies, driving forward research in this critical medical field.
Collaborations
Sayegh has had the opportunity to collaborate with talented professionals, including David S F Young and Helen P Findlay. These collaborations have undoubtedly enriched his research endeavors, allowing for multi-disciplinary approaches in tackling complex challenges within cancer research.
Conclusion
Daad Sayegh stands out as an impactful inventor in the realm of cancer treatment. With his innovative patents and collaborations, he is contributing immensely to the fight against cancer. His work not only enhances our understanding of cancerous diseases but also offers promising avenues for effective treatment strategies.